Cargando…

The association between drospirenone and hyperkalemia: a comparative-safety study

BACKGROUND: Drospirenone/ethinyl-estradiol is an oral contraceptive (OC) that possesses unique antimineralocorticoid activity. It is conjectured that drospirenone, taken alone or concomitantly with spironolactone, may be associated with an increased risk of hyperkalemia. METHODS: A retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bird, Steven T, Pepe, Salvatore R, Etminan, Mahyar, Liu, Xinyue, Brophy, James M, Delaney, Joseph AC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265420/ https://www.ncbi.nlm.nih.gov/pubmed/22208934 http://dx.doi.org/10.1186/1472-6904-11-23

Ejemplares similares

Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
por: Bird, Steven T, et al.
Publicado: (2013)

Drospirenone and mood
por: Zuschmann, Andrew
Publicado: (2022)

A comparative safety study of reported neurological adverse events with three COVID-19 vaccines
por: Sodhi, Mohit, et al.
Publicado: (2022)

Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
por: Sodhi, Mohit, et al.
Publicado: (2020)

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
por: Khanagavi, Jagadish, et al.
Publicado: (2014)

Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes
por: Alrashidi, Tahani Nasser, et al.
Publicado: (2020)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
por: Tan, Jerry KL, et al.
Publicado: (2010)

Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women
por: Blode, Hartmut, et al.
Publicado: (2012)

Preparation and Evaluation of Intravaginal Ring Containing Drospirenone
por: Zhang, Ying, et al.
Publicado: (2013)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review
por: Carranza-Lira, Sebastián
Publicado: (2009)

Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis
por: Shi, Jinghua, et al.
Publicado: (2022)

Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion
por: Fu, Xiao-Dong, et al.
Publicado: (2008)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)

Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
por: Kim, Nayoung, et al.
Publicado: (2015)

Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
por: Palacios, Santiago, et al.
Publicado: (2019)

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
por: Mathur, Ruchi, et al.
Publicado: (2008)

Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia
por: Israni, Rubeen, et al.
Publicado: (2021)

Is There a Relationship between Hyperkalemia and Propofol?
por: Lee, Ju-Hyun, et al.
Publicado: (2011)

A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
por: Wichianpitaya, Jirath, et al.
Publicado: (2013)

EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation
por: Diefenbach, Konstanze, et al.
Publicado: (2013)

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
por: Breech, Lesley L, et al.
Publicado: (2010)

Hyperkalemia and Rhabdomyolyssis
por: Yasri, Sora, et al.
Publicado: (2015)

Course of Hyperkalemia in Patients on Hemodialysis
por: Spinowitz, Bruce, et al.
Publicado: (2022)

Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020)

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database
por: Madigan, David, et al.
Publicado: (2018)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women
por: Park, Bo Ra, et al.
Publicado: (2017)

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
por: Gemzell‐Danielsson, K, et al.
Publicado: (2021)

A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers
por: Melka, Dace, et al.
Publicado: (2020)

Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone
por: Regidor, Pedro-Antonio, et al.
Publicado: (2017)

The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients
por: Lim, Soyi, et al.
Publicado: (2018)

Hyperkalemia and severe rhabdomyolysis
por: Mugmon, Marc
Publicado: (2011)

An unusual manifestation of hyperkalemia
por: Belkouch, Ahmed, et al.
Publicado: (2014)

Hyperkalemia in heart failure
por: Sidhu, Kiran, et al.
Publicado: (2020)

Acute hyperkalemia in adults
por: Emektar, Emine
Publicado: (2023)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

Understanding the molecular association between hyperkalemia and lung squamous cell carcinomas
por: Meng, Xianping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_osv1gam524lifpl6pj5gtcl7en